Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection

Osamu Takeuchi, Katsuaki Hoshino and Shizuo Akira
J Immunol November 15, 2000, 165 (10) 5392-5396; DOI: https://doi.org/10.4049/jimmunol.165.10.5392
Osamu Takeuchi
*Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and
†Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuaki Hoshino
*Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and
†Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shizuo Akira
*Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and
†Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Toll-like receptor (TLR) family acts as pattern recognition receptors for pathogen-specific molecular patterns. We previously showed that TLR2 recognizes Gram-positive bacterial components whereas TLR4 recognizes LPS, a component of Gram-negative bacteria. MyD88 is shown to be an adaptor molecule essential for TLR family signaling. To investigate the role of TLR family in host defense against Gram-positive bacteria, we infected TLR2- and MyD88-deficient mice with Staphylococcus aureus. Both TLR2- and MyD88-deficient mice were highly susceptible to S. aureus infection, with more enhanced susceptibility in MyD88-deficient mice. Peritoneal macrophages from MyD88-deficient mice did not produce any detectable levels of cytokines in response to S. aureus. In contrast, TLR2-deficient macrophages produced reduced, but significant, levels of the cytokines, and TLR4-deficient macrophages produced the same amounts as wild-type cells, indicating that S. aureus is recognized not only by TLR2, but also by other TLR family members except for TLR4.

A bacterial infection is one of the major causes of death even in the present day. Streptococcus aureus, a Gram-positive extracellular growing bacteria, is a major source of mortality in medical facilities (1). It causes a wide range of infections from skin infection to life-threatening diseases including abscesses of various organs, pneumonia, osteomyelitis, endocarditis, arthritis, and sepsis.

Initial host defense against bacterial infection is executed by innate immunity, characterized by the use of germline-encoded receptors for pathogen recognition (2). In Drosophila, Toll family plays a key role in antifungal and antibacterial host defense (3). Recently, mammalian homologues of Toll, designated as Toll-like receptors (TLRs),3 were discovered (4, 5, 6). Each TLR is a type I transmembrane receptor possessing an extracellular leucine-rich repeat and a cytoplasmic Toll/IL-1 receptor homology domain. They are expected to act as pattern recognition receptors, which distinguish pathogen-associated molecular patterns, such as LPS, peptidoglycan (PGN), and lipoprotein (2). Among TLR family members, both TLR2 and TLR4 have been shown to recognize bacterial components. A mutation in the Tlr4 gene is responsible for the phenotype of the C3H/HeJ mouse strain, which is unresponsiveness to LPS, a component of the outer membrane of Gram-negative bacteria (7). Targeted disruption of the Tlr4 gene resulted in abrogation of responses to LPS and lipoteichoic acid (8, 9). In contrast, TLR2 is implicated in the recognition of Gram-positive bacterial components, bacterial lipoproteins, and zymosan (10, 11, 12, 13, 14, 15). TLR2-deficient mice displayed impaired cytokine production in response to Staphylococcus aureus PGN preparation and mycoplasmal lipopeptide (9, 16).

MyD88 is a cytoplasmic adaptor molecule essential for the signaling of IL-1R/TLR family. Ligand binding to IL-1R/TLR family results in the recruitment of MyD88 to Toll/IL-1 receptor domains of receptors, which bridges the signal to IL-1R-associated kinase. Ultimately, the activation of a transcription factor NF-κB occurs and permits the transactivation of proinflammatory cytokine genes (17, 18). We have generated MyD88-deficient mice and shown that MyD88 is essential for cellular responses to IL-1, IL-18, and many bacterial cell wall components such as LPS, PGN, and lipopeptide (19, 20, 21).

C3H/HeJ mice are known to be highly sensitive to infection with Gram-negative bacteria, owing to the failure of LPS recognition (22). Although TLR2 participates in the recognition of Gram-positive bacteria, a substantial role of TLR2 in host defense against Gram-positive bacteria was still unclear. In the present study, we investigated the role of TLR2 and MyD88 in S. aureus infection using mutant mice deficient in these molecules.

Materials and Methods

Mice

The mutant mouse (F2 interbred from 129/Ola × C57BL/6) strains deficient in TLR2, TLR4, or MyD88 were generated by gene targeting as described previously (8, 9, 19). MyD88-deficient mice were backcrossed eight times with C57BL/6 mice. For S. aureus infection, groups of TLR2-deficient mice and wild-type littermates or MyD88-deficient mice (C57BL/6 background) and wild-type littermates were used. Age-matched groups of wild-type, TLR2-, TLR4-, and MyD88-deficient mice were used for the other experiment.

Bacteria and infection

S. aureus 834 strain (gift from A. Nakane, Hirosaki University, Japan) was classified as coagulase type II, produced toxic shock syndrome toxin I and methicillin resistant (23), and it was prepared as described previously (23, 24). In brief, bacteria were cultured on trypticase soy agar (Becton Dickinson, Sparks, MD), inoculated with trypticase soy broth, and incubated for 15 h at 37°C. The bacteria were collected and resuspended by PBS. The concentration of resuspended cells was adjusted spectrophotometrically at 550 nm. Mice were given i.v. injections of 0.2 ml of bacterial solution containing 1 × 107 CFU of viable S. aureus and their survival was monitored for up to 14 days. S. aureus suspension (1 × 109 CFU/ml in PBS) was boiled for 30 min and used as heat-killed S. aureus.

Determination of the number of bacteria in blood and organs

Mice were given 1 × 107 CFU or 1 × 106 CFU of S. aureus as an i.v. infection, and they were killed 1, 2, or 5 days later. Spleens and kidneys were dissected, homogenized, and diluted in 10-fold steps in sterile water containing 0.5% Triton X-100 (Nacalai Tesque, Kyoto, Japan). Blood was also diluted in water containing 0.5% Triton X-100. Bacterial CFU was determined by plating each dilution on trypticase soy agar and was cultured for 24 h at 37°C.

Preparation of peritoneal macrophages

Mice were i.p. injected with 2 ml of 4% thioglycolate (Difco, Detroit, MI). Three days later, peritoneal exudate cells were isolated from the peritoneal cavity by washing with ice-cold HBSS (Life Technologies, Rockville, MD). Cells were cultured for 2 h and washed with HBSS to remove nonadherent cells. Adherent monolayer cells were used as peritoneal macrophages. Peritoneal macrophages (5 × 105/ml) were cultured in RPMI 1640 medium (Nacalai Tesque) supplemented with 10% FCS and stimulated with 1 × 107 CFU/ml of heat-killed S. aureus for 24 h. Concentration of TNF-α in culture supernatant was determined by ELISA (Genzyme Techne, Minneapolis, MN) and IL-6 concentration was also measured by ELISA (Endogen, Boston, MA).

Statistical analysis

Kaplan-Meier plots were conducted and the log rank test was used to test the differences in the survival between wild-type and TLR2-deficient or MyD88-deificient mice. The significances of the difference between the groups in the numbers of bacteria and cytokine concentrations were tested using Mann-Whitney U test.

Results

Decreased survival of TLR2-deficient mice after infection with S. aureus

We have previously shown that TLR2 is required for the recognition of PGN from S. aureus. Moreover, TLR2-deficient macrophages did not produce TNF-α in response to cell wall preparation from S. aureus (9). To evaluate the in vivo role of TLR2 against S. aureus infection, wild-type and TLR2-deficient mice were infected i.v. with 1 × 107 CFU of S. aureus and their survival was monitored. As shown in Fig. 1⇓, all wild-type mice survived for 8 days after S. aureus inoculation and 60% survived on day 14. In contrast, about 80% of TLR2-deficient mice succumbed to S. aureus and died within 8 days, and only 10% survived on day 14 (p < 0.03). However, when a low dose (1 × 106 CFU) of S. aureus was administered in the mice, the survival was not altered between wild-type and TLR2-deficient mice (data not shown). To investigate whether this susceptibility was the result of altered bacterial distribution and growth in vivo, the bacterial numbers in the blood, spleen, and kidney of mice were determined at 1 and 2 days after 1 × 107 CFU of S. aureus infection. At both 1 and 2 days, the number of S. aureus in the blood and kidney were higher in TLR2-deficient mice, consistent with high morbidity and mortality of TLR2-deficient mice after infection with S. aureus (Fig. 2⇓A). When the mice were inoculated with 1 × 106 CFU of S. aureus, a statistically significant difference was not observed in the bacterial numbers between wild-type and TLR2-deficient organs at both 2 and 5 days after inoculum (Fig. 2⇓B).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Survival of TLR2-deficient mice (n = 10, ▪) and wild-type mice (n = 10, ○) after i.v. infection of 1 × 107 CFU of S. aureus. p < 0.03 in log rank test.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Numbers of live S. aureus in TLR2-deficient and wild-type mice after injection of bacteria. TLR2-deficient mice (n = 4 or 5) and wild-type mice (n = 4 or 5) were infected i.v. with 1 × 107 CFU (A) or 1 × 106 CFU (B) S. aureus. The blood and organs were collected 1 and 2 days (A) or 2 and 5 days (B) after injection, and bacterial counts were determined by culture on agar. Data are represented as the mean number of CFU ± SD. ∗, p < 0.05 in Mann-Whitney U test.

High susceptibility of MyD88-deficient mice to S. aureus infection

MyD88 is an adaptor molecule essential for the signaling of the IL-1R/TLR family. We have previously shown that MyD88-deficient mice lacked responsiveness to IL-1, IL-18, and LPS (19, 20). S. aureus PGN-induced TNF-α production was also abrogated in MyD88-deficient macrophages, indicating the role of MyD88 in anti-Gram-positive bacterial host defense (21). Therefore, we infected MyD88-deficient mice with S. aureus and monitored their survival. After inoculation with 1 × 107 S. aureus, all MyD88-deficient mice succumbed to infection and died within 5 days, whereas 80% of wild-type mice survived for 14 days (p < 0.0003,Fig. 3⇓). MyD88-deficient mice died more rapidly than TLR2-deficient mice. Next, the number of bacterial cells in the blood, spleen, and kidney were determined at 1 day of 1 × 107 CFU S. aureus infection. Bacterial numbers in the blood and kidney were increased in MyD88-deficient mice compared with wild-type mice (Fig. 4⇓A). Even when the mice were inoculated with a lower dose of bacteria (1 × 106 CFU), the bacterial numbers in the organs from MyD88-deficient mice were significantly higher than those from wild-type mice (Fig. 4⇓B). These results indicate that MyD88-deficient mice are more susceptible to S. aureus infection than TLR2-deficient mice.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Survival of MyD88-deficient mice (n = 10, ○) and wild-type mice (n = 10, ▪) after i.v. infection of 1 × 107 CFU of S. aureus. p < 0.0003 in log rank test.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Numbers of live S. aureus in MyD88-deficient and wild-type mice after injection of bacteria. MyD88-deficient mice (n = 3 or 4) and wild-type mice (n = 3 or 4) were infected i.v. with 1 × 107 CFU (A) or 1 × 106 CFU (B) S. aureus. The blood and organs were collected 1 (A) or 2 days and 5 days (B) after injection, and bacterial counts were determined by culture on agar. Data are represented as the mean number of CFU ± SD. ∗, p < 0.05 in Mann-Whitney U test.

Role of TLR2 and MyD88 in the cytokines production in response to heat-killed S. aureus

Furthermore, we examined the responsiveness of peritoneal macrophages from wild-type, TLR2-, and MyD88-deficient mice to heat-killed S. aureus. Thioglycolate-elicited peritoneal macrophages were cultured in the presence of 1 × 107 CFU/ml of S. aureus for 24 h, and concentrations of TNF-α and IL-6 in culture supernatant were measured. Macrophages from wild-type and TLR4-deficient mice produced almost the same amount of TNF-α in response to heat-killed S. aureus. TLR2-deficient macrophages produced a reduced, but significant level of TNF-α. In contrast, MyD88-deficient macrophages did not produce any detectable TNF-α (Fig. 5⇓A). IL-6 production in response to S. aureus was also reduced in TLR2-deficient macrophages and abrogated in MyD88-deficient macrophages (Fig. 5⇓B).

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Production of TNF-α and IL-6 in response to heat-killed S. aureus in TLR2-, TLR4-, and MyD88-deficient macrophages. Peritoneal macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice were cultured in the presence of 1 × 107 CFU/ml of heat-killed S. aureus for 24 h. Concentrations of TNF-α (A) and IL-6 (B) in the culture supernatants were measured by ELISA. The results are representative of three independent experiments and are shown as the mean ± SEM of triplicate wells. ∗, p < 0.05 in Mann-Whitney U test. N.D., Not detected.

Discussion

The present study demonstrated the critical role of TLR2 and MyD88 against extracellular Gram-positive bacteria using knockout mice. Both TLR2- and MyD88-deficient mice developed higher mortality compared with wild-type mice after inoculation with S. aureus. These are associated with a bacterial growth in the blood and kidney. We have previously shown that S. aureus PGN-induced cytokine production was dependent on TLR2 (9). Thus, failure of recognizing invading bacteria is responsible for high susceptibility in TLR2-deficient mice. It was reported that C3H/HeJ mice, possessing a point mutation in the Tlr4 gene, are highly susceptible to infection with Salmonella typhimurium. LD50 value of the bacteria for C3H/HeJ mouse strain was <2, in contrast to the resistance of C3H/HeN mice to S. typhimurium infection (LD50 = 1 × 104) (22). These observations indicate the distinct roles of TLR2 and TLR4 in discriminating invading pathogens.

MyD88-deficient mice were also highly susceptible to S. aureus infection and they were more susceptible to infection than TLR2-deficient mice. We have shown that MyD88-deficient mice display the defective response to many bacterial components and IL-1 family cytokines such as IL-1 and IL-18 (19). Both severely impaired bacterial recognition and failure of signaling mediated by IL-1 family cytokines may contribute to the susceptibility of MyD88-deficient mice to infection.

We have previously shown that S. aureus cell wall-mediated TNF-α production was fully TLR2 dependent (9). Therefore, it was surprising that the production of proinflammatory cytokine was induced in response to heat-killed S. aureus in TLR2-deficient macrophages, although the level was reduced compared with that in wild-type macrophages. In contrast, bacteria-mediated TNF-α production was abrogated in MyD88-deficient cells. Although TLR4-deficient macrophages displayed impaired responsiveness to Gram-positive lipoteichoic acids, TLR4-deficient macrophages re-sponded to heat-killed S. aureus to the same extent as wild-type cells, indicating that lipoteichoic acid on S. aureus cell surfaces may not significantly contribute to cellular activations. These results suggest that S. aureus is recognized not only by TLR2, but also by other TLR/IL-1R family members except for TLR4. A previous report demonstrated that the treatment with anti-TNF-α Ab to mice after inoculation of S. aureus increased the death rate (23). Our results also indicate the correlation between the S. aureus-induced TNF-α production and the resistance of mice to the infection.

Taken together, innate recognition of bacteria by TLR family members is quite important for eliminating invading bacteria. Particularly, TLR2 plays a crucial role in host defense against extracellular growing Gram-positive bacteria. Similarly, high mortality after S. aureus infection and complete abrogation of proinflammatory cytokine secretion in MyD88-deficient mice shows an essential role of MyD88 in resistance to Gram-positive bacterial infection.

Acknowledgments

We thank Dr. Akio Nakane for providing S. aureus 834 strain, Dr. Yoshihumi Takeda for helpful suggestions, and Dr. Hiroko Tsutsui for providing mice. We thank T. Aoki for excellent secretarial assistance and N. Tsuji and E. Nakatani for excellent technical assistance.

Footnotes

  • ↵1 This work was supported by grants from the Ministry of Education of Japan.

  • ↵2 Address correspondence and reprint requests to Dr. Shizuo Akira, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail address: sakira{at}biken.osaka-u.ac.jp

  • ↵3 Abbreviations used in this paper: TLR, Toll-like receptor; PGN, peptidoglycan.

  • Received May 31, 2000.
  • Accepted September 13, 2000.
  • Copyright © 2000 by The American Association of Immunologists

References

  1. ↵
    Lowy, F. D.. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520
    OpenUrlCrossRefPubMed
  2. ↵
    Medzhitov, R., C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a monclonal system of recognition. Cell 91: 295
    OpenUrlCrossRefPubMed
  3. ↵
    Kopp, E. B., R. Medzhitov. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11: 13
    OpenUrlCrossRefPubMed
  4. ↵
    Medzhitov, R., P. Preston-Hurburt, C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394
    OpenUrlCrossRefPubMed
  5. ↵
    Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231: 59
    OpenUrlCrossRefPubMed
  7. ↵
    Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. TLR4-deficient mice are hyporesponsive to LPS: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, T. Ogawa, H. Takada, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443
    OpenUrlCrossRefPubMed
  10. ↵
    Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406.
  11. ↵
    Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, D. Golenbock. 1999. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Brightbill, D. H., H. D. Libraty, R. S. Krutzik, B. R. Yang, T. J. Belisle, R. J. Bleharski, M. Maitland, V. M. Norgard, E. S. Plevy, T. S. Smale, et al 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-Like receptors. Science 285: 732
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Aliprantis, O. A., R. B. Yang, R. M. Mark, S. Suggett, B. Devaux, D. J. Radolf, R. G. Klimpel, P. Godowski, A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285: 736
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811
    OpenUrlCrossRefPubMed
  16. ↵
    Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr, P. F. Muhlradt, S. Akira. 2000. Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164: 554
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Muzio, M., G. Natoli, S. Saccani, M. Levrero, A. Mantovani. 1998. The human Toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187: 2097
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253
    OpenUrlCrossRefPubMed
  19. ↵
    Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD 88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143
    OpenUrlCrossRefPubMed
  20. ↵
    Kawai, T., O. Adachi, T. Ogawa, K. Takeda, S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115
    OpenUrlCrossRefPubMed
  21. ↵
    Takeuchi, O., K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int, Immunol. 12: 113
    OpenUrlAbstract/FREE Full Text
  22. ↵
    O’Brien, A. D., D. L. Rosenstreich, I. Scher, G. H. Campbell, R. P. MacDermott, S. B. Formal. 1980. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124: 20
    OpenUrlPubMed
  23. ↵
    Nakane, A., M. Okamoto, M. Asano, M. Kohanawa, T. Minagawa. 1995. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63: 1165
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Sasaki, S., T. Miura, S. Nishikawa, K. Yamada, M. Hirasue, A. Nakane. 1998. Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect. Immun. 66: 1017
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 165 (10)
The Journal of Immunology
Vol. 165, Issue 10
15 Nov 2000
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection
Osamu Takeuchi, Katsuaki Hoshino, Shizuo Akira
The Journal of Immunology November 15, 2000, 165 (10) 5392-5396; DOI: 10.4049/jimmunol.165.10.5392

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection
Osamu Takeuchi, Katsuaki Hoshino, Shizuo Akira
The Journal of Immunology November 15, 2000, 165 (10) 5392-5396; DOI: 10.4049/jimmunol.165.10.5392
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
  • Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606